Zobrazeno 1 - 10
of 997
pro vyhledávání: '"Weinkove R"'
Autor:
Cochrane T; Department of Haematology, Gold Coast University Hospital, Southport, Australia.; School of Medicine, Griffiths University, Parkwood, Queensland, Australia., Enrico A; Area Hematology, Hospital Italiano La Plata, Buenos Aires, Argentina., Gomez-Almaguer D; Hematology Service, Hospital Universitario, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Mexico., Hadjiev E; Department of Internal Medicine, Medical University Sofia, University Hospital Alexandrovska, Sofia, Bulgaria., Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Masszi T; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Nikitin E; Department of Hematology, Oncology and Chemotherapy, S. P. Botkin's City Hospital, Moscow, Russia., Robak T; Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland., Weinkove R; Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand.; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand., Wu SJ; Department of Internal Medicine, Division of Haematology, National Taiwan University Hospital, Taipei City, Taiwan., Manzoor BS; AbbVie, Inc., North Chicago, IL, USA., Busman T; AbbVie, Inc., North Chicago, IL, USA., Pai M; AbbVie, Inc., North Chicago, IL, USA., Komlosi V; AbbVie Schweiz AG, Cham, Switzerland., Anderson MA; The Clinical Haematology Department of the Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Division of Blood Cells and Blood Cancer, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov; Vol. 65 (11), pp. 1743-1746. Date of Electronic Publication: 2023 Aug 25.
Autor:
Al-Sawaf O; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Zhang C; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Olivieri S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chang YM; F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada., Fink AM; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Tausch E; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Schneider C; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Ritgen M; Universitätsklinikum Schleswig Holstein, Kiel, Germany., Kreuzer KA; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Sivchev L; Multiprofile Hospital for Active Treatment Pazardjik, Pazardzhik, Bulgaria., Niemann CU; Rigshospitalet, Copenhagen, Denmark., Schwarer A; Box Hill Hospital, Box Hill, VIC, Australia., Loscertales J; Hospital De La Princesa, Madrid, Spain., Weinkove R; Te Rerenga Ora Wellington Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital, Wellington, New Zealand.; Cancer Immunotherapy Program, Malaghan Institute of Medical Research, Wellington, New Zealand., Strumberg D; Evangelisches Krankenhaus Herne, Herne, Germany., Kilfoyle A; Palmerston North Hospital, Palmerston North, New Zealand., Manzoor BS; AbbVie Inc, Chicago, IL., Jawaid D; AbbVie Inc, Chicago, IL., Emechebe N; AbbVie Inc, Chicago, IL., Devine J; Genentech Inc, South San Francisco, CA., Boyer M; F. Hoffmann-La Roche Ltd, Welwyn, United Kingdom., Runkel ED; AbbVie Inc, Chicago, IL., Eichhorst B; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Stilgenbauer S; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Jiang Y; Genentech Inc, South San Francisco, CA., Hallek M; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Fischer K; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.
Publikováno v:
Blood [Blood] 2024 Oct 31; Vol. 144 (18), pp. 1924-1935.
Autor:
Blud D; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand., Rubio-Reyes P; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand., Perret R; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand., Weinkove R; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand; Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand; Department of Pathology and Molecular Medicine, University of Otago Wellington, Wellington, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand. Electronic address: rweinkove@malaghan.org.nz.
Publikováno v:
Seminars in hematology [Semin Hematol] 2024 Oct; Vol. 61 (5), pp. 333-344. Date of Electronic Publication: 2024 Jul 06.
Autor:
Brown JR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Eichhorst B; University of Cologne, Cologne, Germany., Lamanna N; Columbia University Medical Center, New York, New York, United States., O'Brien SM M.D; Chao Family Comprehensive Cancer Center at UC Irvine Medical Center, Orange, California, United States., Tam CS; Alfred Health and Monash University, East Melbourne, Australia., Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Zhou K; Henan Cancer Hospital, Zhengzhou, China, Zhengzhou, China., Šimkovič M; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic, Hradec Kralove, Czech Republic., Mayer J; University Hospital Brno., Gillespie-Twardy A; Blue Ridge Cancer Care, Roanoke, Virginia, United States., Ferrajoli A; the University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States., Ganly PS; Christchurch Hospital, Christchurch, New Zealand., Weinkove R; Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand., Grosicki S; Silesian Medical University in Katowice, Chorzow, Poland., Mital A; Medical University of Gdańsk, Gdansk, Poland., Robak T Prof; Medical University of Lodz, Lodz, Poland., Osterborg A; Karolinska Institutet, Stockholm, Sweden., Yimer HA; Texas Oncology, Tyler, Texas, United States., Wang MY; BeiGene USA, Inc., San Mateo, California, United States., Salmi T; BeiGene International GmbH, Basel, Switzerland., Wang L; BeiGene (Beijing) Co., Ltd., China., Li J; Beigene, San Mateo,, California, United States., Wu K; BeiGene USA, Inc., San Mateo, California, United States., Cohen AC; BeiGene, San mateo, California, United States., Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States.
Publikováno v:
Blood [Blood] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.
Autor:
Lasica M; Department of Clinical Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.; The University of Melbourne, Melbourne, Victoria, Australia., Anderson MA; Department of Clinical Haematology, Royal Melbourne Hospital and The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia., Boussioutas A; Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia.; Monash University, Melbourne, Victoria, Australia.; The Alfred, Melbourne, Victoria, Australia.; Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gregory GP; Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.; Monash Haematology, Monash Health, Melbourne, Victoria, Australia., Hamad N; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia., Manos K; Department of Haematology, Flinders Medical Centre, Adelaide, South Australia, Australia., McKelvie P; Department of Anatomical Pathology, St Vincent's Hospital, Melbourne, Victoria, Australia., Ng M; GenesisCare St Vincent's Hospital, Melbourne, Victoria, Australia., Campbell B; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia., Palfreyman E; Department of Haematology, Royal Darwin Hospital, Darwin, Northern Territory, Australia., Salvaris R; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia., Weinkove R; Te Rerenga Ora Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand.; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Department of Pathology and Molecular Medicine, University of Otago Wellington, Wellington, New Zealand., Wight J; Department of Haematology and Bone Marrow Transplantation, Townsville University Hospital, Townsville, Queensland, Australia.; School of Medicine, James Cook University, Townsville, Queensland, Australia., Opat S; Monash Haematology, Monash Health, Melbourne, Victoria, Australia.; School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia., Tam C; Haematology Department, Alfred Hospital, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Publikováno v:
Internal medicine journal [Intern Med J] 2024 Jun; Vol. 54 (6), pp. 1017-1030.
Autor:
MacPhail A; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Monash Health, Clayton, Victoria, Australia., Dendle C; Department of Infectious Diseases, Monash Health, Clayton, Victoria, Australia.; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia., Slavin M; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Weinkove R; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Te Rerenga Ora Wellington Blood & Cancer Centre, Wellington Hospital, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand., Bailey M; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia., Pilcher D; Department of Intensive Care, Alfred Health, Prahran, Victoria, Australia.; Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (ANZICS CORE), Prahran, Victoria, Australia.; The Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventative Medicine, Monash University, Prahran, Victoria, Australia., McQuilten Z; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.; Department of Haematology, Monash Health, Clayton, Victoria, Australia.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 May 19; Vol. 11 (6), pp. ofae289. Date of Electronic Publication: 2024 May 19 (Print Publication: 2024).
Autor:
Carrillo de Albornoz S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Centre for Health Economics, Monash University, Melbourne, Australia., Higgins AM; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Petrie D; Centre for Health Economics, Monash University, Melbourne, Australia., Irving A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Centre for Health Economics, Monash University, Melbourne, Australia., Fanning L; Centre for Health Economics, Monash University, Melbourne, Australia., Weinkove R; Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand.; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Department of Pathology & Molecular Medicine, University of Otago Wellington, Wellington, New Zealand., Crispin P; Canberra Hospital, Canberra, Australia.; School of Medicine and Psychology, Australian National University, Canberra, Australia., Dendle C; Monash Infectious Diseases, Monash Health, Melbourne, Australia.; School of Clinical Sciences, Monash University, Melbourne, Australia., Gilbertson M; Department of Clinical Haematology, Monash Health, Melbourne, Australia., Johnston A; Royal Hobart Hospital, Hobart, Australia.; University of Tasmania, Hobart, Australia., Keegan A; PathWest Laboratory Medicine, King Edward Memorial Hospital, Perth, Australia., Pepperell D; Department of Haematology, Fiona Stanley Hospital, Perth, Australia., Pullon H; Department of Haematology, Waikato Hospital, Hamilton, New Zealand., Reynolds J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia., van Tonder T; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Trotman J; Concord Repatriation General Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia., Waters N; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Wellard C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Weston H; Sunshine Coast University Hospital, Sunshine Coast, Australia., Morrissey CO; Central Clinical School, Monash University, Melbourne, Australia.; Department of Infectious Diseases, Alfred Health, Melbourne, Australia., Wood EM; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., McQuilten ZK; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Clinical Haematology, Monash Health, Melbourne, Australia.
Publikováno v:
Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2259-2267.
Autor:
MacPhail A; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.; Department of Infectious Diseases, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia., Dendle C; Department of Infectious Diseases, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, 246 Clayton Road, Clayton, VIC, 3004, Australia., Slavin M; Department of Infectious Diseases, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.; National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, 305 Grattan Street, Melbourne, VIC, 3000, Australia., Weinkove R; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Te Rerenga Ora Wellington Blood and Cancer Centre, Wellington Hospital, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, 6021, New Zealand., Bailey M; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia., Pilcher D; Department of Intensive Care, Alfred Health, 55 Commercial Road, Prahran, VIC, 3004, Australia.; Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (ANZICS-CORE), 101 High St Prahran, Victoria, 3001, Australia.; The Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Prahran, VIC, 3004, Australia., McQuilten Z; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia. Zoe.mcquilten@monash.edu.; Department of Haematology, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia. Zoe.mcquilten@monash.edu.
Publikováno v:
Critical care (London, England) [Crit Care] 2024 May 06; Vol. 28 (1), pp. 148. Date of Electronic Publication: 2024 May 06.
Autor:
McQuilten ZK; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Monash Health, Melbourne, Australia., Weinkove R; Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand.; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Department of Pathology & Molecular Medicine, University of Otago Wellington, Wellington, New Zealand., Thao LTP; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Crispin P; Department of Haematology, Canberra Hospital, Canberra, Australia., Degelia A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Dendle C; Monash Infectious Diseases, Monash Health, Melbourne, Australia.; School of Clinical Sciences, Monash University, Melbourne, Australia., Gilbertson M; Department of Haematology, Monash Health, Melbourne, Australia., Johnston A; Department of Haematology, Royal Hobart Hospital, Hobart, Australia.; Department of Medicine, University of Tasmania, Hobart, Australia., Keegan A; PathWest Laboratory Medicine, King Edward Memorial Hospital, Perth, Australia., Pepperell D; Department of Haematology, Fiona Stanley Hospital, Perth, Australia., Pullon H; Department of Haematology, Waikato Hospital, Hamilton, New Zealand., Reynolds J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Central Clinical School, Monash University, Melbourne, Australia., van Tonder T; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Trotman J; Department of Haematology, Concord Repatriation General Hospital, Sydney, Australia.; Concord Clinical School, University of Sydney, Sydney, Australia., Waters N; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Wellard C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Weston H; Department of Haematology, Sunshine Coast University Hospital, Sunshine Coast, Australia., Morrissey CO; Central Clinical School, Monash University, Melbourne, Australia.; Department of Infectious Diseases, Alfred Health, Melbourne, Australia., Wood EM; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Monash Health, Melbourne, Australia.
Publikováno v:
Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1787-1795.
Autor:
Brown JR; The Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Eichhorst B; The Department of Internal Medicine, University of Cologne, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Cologne, Germany., Hillmen P; St. James's University Hospital, Leeds, United Kingdom., Jurczak W; Maria Skłodowska-Curie National Research Institute of Oncology, Krakow, Poland., Kaźmierczak M; The Department of Hematology & Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland., Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA., O'Brien SM; Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA., Tam CS; The Alfred Hospital & Monash University, Melbourne, VIC, Australia., Qiu L; The State Key Laboratory of Experimental Hematology, National Clinical Medical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Zhou K; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Simkovic M; The Fourth Department of Internal Medicine-Hematology, University Hospital, Hradec Kralove, Czech Republic, & The First Faculty of Medicine, Charles University, Prague, & the Department of Internal Medicine, Prague, Czech Republic., Mayer J; Hematology & Oncology, Masaryk University & University Hospital, Brno, Czech Republic., Gillespie-Twardy A; Blue Ridge Cancer Care, Roanoke, Virginia, USA., Ferrajoli A; The Leukemia Department, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Ganly PS; The Department of Haematology, Christchurch Hospital, Christchurch, New Zealand., Weinkove R; Te Rerenga Ora Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, & the Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand., Grosicki S; The Department of Hematology & Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland., Mital A; The Department of Hematology & Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Robak T; The Medical University of Lodz, Lodz, Poland., Osterborg A; The Department of Oncology-Pathology, Karolinska Institutet, Stockholm & the Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Yimer HA; Texas Oncology-Tyler, US Oncology Network, Tyler, Texas, USA., Salmi T; BeiGene International GmbH, Basel, Switzerland., Wang MD; BeiGene USA, San Mateo, California, USA., Fu L; Formerly of BeiGene., Li J; BeiGene (Beijing), Beijing, China., Wu K; BeiGene USA, San Mateo, California, USA., Cohen A; BeiGene USA, San Mateo, California, USA., Shadman M; The Fred Hutchinson Cancer Center & the Department of Medicine, University of Washington, Seattle, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Apr; Vol. 20 (12), pp. 717-726. Date of Electronic Publication: 2023 Dec 13.